C83.0A
BillableSmall cell B-cell lymphoma, in remission
HCC Category Mapping
V28HCC 21 — Breast, Prostate, Colorectal and Other Cancers and Tumors
0.545V24HCC 10 — Lymphoma and Other Cancers
0.675ESRDHCC 10 — Lymphoma and Other Cancers
0.000RxHCCHCC 21 — Hodgkin Lymphoma and Other Cancers
0.000What This Code Means
Small cell B-cell lymphoma that is currently in remission, meaning cancer cells are no longer detectable.
Coding Tips
- •Only use this code when documentation explicitly states 'in remission' or 'in complete remission'
- •Do not use if patient has relapsed or if remission status is unclear
Clinical Significance
Small cell B-cell lymphoma in remission indicates the patient has achieved a treatment response where cancer is no longer detectable. This code is essential for ongoing risk adjustment capture, as patients in remission still require surveillance, have relapse risk, and may be on maintenance therapy. The distinction between active disease and remission is clinically significant.
Documentation Requirements
- ✓Explicit provider statement of 'in remission' or 'complete remission'
- ✓Type of remission (complete vs. partial — code only for confirmed remission)
- ✓Date remission was achieved
- ✓Ongoing surveillance plan (imaging schedule, lab monitoring)
- ✓Current medications including any maintenance therapy
Commonly Confused Codes
C83.00 — Unspecified site (active disease); do not use active disease codes when remission is documentedZ85.79 — Personal history of other malignant neoplasm of lymphoid tissue; use when lymphoma is no longer being monitored or treated, not during active remission surveillanceC83.01-C83.09 — Active site-specific codes; once remission is achieved, the site-specific code is replaced by C83.0A